Copyright
©The Author(s) 2022.
World J Clin Cases. Nov 16, 2022; 10(32): 11804-11811
Published online Nov 16, 2022. doi: 10.12998/wjcc.v10.i32.11804
Published online Nov 16, 2022. doi: 10.12998/wjcc.v10.i32.11804
Table 4 Multivariate Cox analysis affecting patient outcomes
Variables | r | SD | Wald | P value | OR | 95%CI |
Bone marrow infiltration | 0.820 | 0.251 | 10.686 | 0.001 | 2.270 | 1.472-3.934 |
Clinical stages | 1.537 | 0.419 | 13.478 | < 0.001 | 4.649 | 2.940-15.168 |
IPI score | 0.949 | 0.273 | 12.074 | 0.001 | 2.582 | 1.626-4.741 |
Tim-3 expression | 1.027 | 0.279 | 13.540 | < 0.001 | 2.792 | 1.744-5.207 |
TGF-β expression | 1.195 | 0.360 | 11.010 | 0.001 | 3.304 | 1.954-8.019 |
CXCL12 expression | 1.305 | 0.401 | 10.600 | 0.001 | 3.688 | 2.102-10.117 |
- Citation: Wu H, Sun HC, Ouyang GF. T-cell immunoglobulin mucin molecule-3, transformation growth factor β, and chemokine-12 and the prognostic status of diffuse large B-cell lymphoma. World J Clin Cases 2022; 10(32): 11804-11811
- URL: https://www.wjgnet.com/2307-8960/full/v10/i32/11804.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i32.11804